CTSI director honored for work in lung cancer research and treatment

Dr. Steven Dubinett, director of the UCLA CTSI, has been honored by the American Lung Association for his work on research and treatment of lung cancer.

Dubinett, a professor of medicine, pathology and laboratory medicine, and molecular and medical pharmacology at the David Geffen School of Medicine at UCLA and lung cancer researcher in the UCLA Jonsson Comprehensive Cancer Center, was honored at the association’s Lung Force Gala for advancing academic, clinical and community partnerships designed to accelerate scientific discoveries and clinical breakthroughs in order to improve the health of people worldwide.

“It is such an honor to be recognized by an organization who has supported my research since day one,” said Dubinett. “This honor isn’t just about me, but highlights the work of our laboratory members and our collaborators for their critical insights and exceptional creativity, which are leading to translational discoveries for patients with lung cancer.”

See the UCLA Jonsson Comprehensive Cancer Center press release for the full story on his research that began more than 30 years ago.

Dubinett is the chief of pulmonary, critical care, sleep medicine, clinical immunology and allergy at UCLA, and the associate vice chancellor and senior associate dean for translational research. 

More information:
UCLA Newsroom press release

Image source: UCLA

Image caption: Steven M. Dubinett, MD